Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter revision tag updated from v3.2.0 to v3.3.2; no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedDeleted the government funding operating status notice that was previously displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe new screenshot shows minor UI adjustments and reorganization; core study details, eligibility criteria, and outcome measures appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedPage now shows version v3.2.0 and a government-operating-status notice; old version v3.1.0 is removed.SummaryDifference5%

- Check78 days agoChange DetectedUpdated the page from version v3.0.2 to v3.1.0, reflecting a new software/document version.SummaryDifference0.1%

- Check93 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed.SummaryDifference0.3%

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.